lobbying_activities: 1438957

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1438957	3d6fc421-5520-4897-8753-a40ee26ab480	Q3	CAPITOL HILL CONSULTING GROUP	72053	WELLNESS PHARMACY	2013	third_quarter	PHA	Pharmaceutical Compounding and Accountability Act (S.959) The Compounding Clarity Act (HR 3089) The Drug Quality and Security Act (HR 3204)	HOUSE OF REPRESENTATIVES,SENATE	6750		0	0	2013-10-08T15:03:38.857000-04:00